Detalus Advisors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.9M Hold
10,000
0.76% 28
2026
Q1
$4.73M Hold
10,000
1.08% 22
2025
Q4
$4.67M Hold
10,000
1.14% 21
2025
Q3
$4.26M Hold
10,000
1.1% 22
2025
Q2
$3.83M Hold
10,000
1.11% 19
2025
Q1
$3.46M Hold
10,000
1.09% 21
2024
Q4
$3M Hold
10,000
0.99% 22
2024
Q3
$4.06M Hold
10,000
1.35% 17
2024
Q2
$3.21M Hold
10,000
1.1% 20
2024
Q1
$3.34M Hold
10,000
1.19% 20
2023
Q4
$2.71M Hold
10,000
1.08% 18
2023
Q3
$2.46M Hold
10,000
1.15% 18
2023
Q2
$3.03M Hold
10,000
1.36% 15
2023
Q1
$2.64M Buy
+10,000
New +$2.54M 1.26% 16

Other funds holding HCA

Detalus Advisors's HCA Position: Q2 2026 in Review

Detalus Advisors held its HCA Healthcare (HCA) position steady in Q2 2026 at 10,000 shares worth $3.9M. The position accounts for 0.76% of the portfolio, ranked #28.

Detalus Advisors first reported a position in HCA in Q1 2023 and has held it in 14 quarters since. The position peaked at $4.73M in Q1 2026. 1,339 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Detalus Advisors held 10,000 shares of HCA Healthcare worth $3.9M as of Q2 2026.
  • Detalus Advisors left its HCA Healthcare share count unchanged in Q2 2026.
  • HCA Healthcare made up 0.76% of Detalus Advisors's portfolio in Q2 2026, its #28 holding.
  • Detalus Advisors first reported a position in HCA Healthcare in Q1 2023 and has held it in 14 quarters since.
  • Detalus Advisors's HCA Healthcare position peaked at $4.73M in Q1 2026.
  • 1,339 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Detalus Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.